A carregar...
Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV(1) level: a patient-level pooled analysis of phase-3 randomized clinical trials
BACKGROUND: Which patients should receive dual therapy as initial treatment for chronic obstructive pulmonary disease (COPD) is only loosely defined. We evaluated if a lower forced expiratory volume in 1 s (FEV(1)) identifies a population more likely to benefit from dual therapy than monotherapy amo...
Na minha lista:
| Publicado no: | Respir Res |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7881547/ https://ncbi.nlm.nih.gov/pubmed/33579288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-021-01648-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|